Centessa Pharmaceuticals plc (CNTA) Tops Q1 EPS by 16c
Tweet
Share
E-mail
Get Alerts CNTA Hot Sheet
Join SI Premium – FREE
Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q1 EPS of ($0.20), $0.16 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $15 million versus the consensus estimate of $0 .
For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Downgrades DKSH Holding AG (DKSH:SW) to Hold
- Broadcom credit risk measures rise amid AI financing deals
- Bernstein SocGen Group Upgrades Square Enix Holdings (9684:JP) (SQNNY) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
